Verdad Advisers
Verdad Advisers reported 210 stocks worth $104M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are AAPL (2.1%), BLTE (2.0%) and ACAD (2.0%). Compared with Q1 2026, the fund opened new positions in AAPL, XFOR and JBIO, added to ACAD, CMCSA and TENX, trimmed BLTE, ZYME and JNJ and sold out of STT, ATHM and CALM.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 4 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  AAPL Apple Inc | $2.2M | 2.1% | 7,445 | New position | 3 of 4 | |
| 2 |  BLTE Belite Bio Inc | $2.1M | 2.0% | 14K | −55 (−0%) | 2 of 4 | |
| 3 |  ACAD Acadia Pharmaceuticals Inc | $2.1M | 2.0% | 83K | +14K (+21%) | 2 of 4 | |
| 4 |  CMCSA Comcast Corp New | $2.1M | 2.0% | 85K | +43K (+104%) | 3 of 4 | |
| 5 |  CLDT Chatham Lodging TR | $1.9M | 1.8% | 140K | No change | 3 of 4 | |
| 6 |  TENX Tenax Therapeutics Inc | $1.8M | 1.7% | 123K | +28K (+29%) | 2 of 4 | |
| 7 |  SLDE Slide Ins Hldgs Inc | $1.8M | 1.7% | 91K | +60K (+197%) | 2 of 4 | |
| 8 |  ZYME Zymeworks Inc | $1.7M | 1.7% | 67K | −16K (−19%) | 2 of 4 | |
| 9 |  AMN Amn Healthcare Svcs Inc | $1.7M | 1.6% | 52K | +1,906 (+4%) | 3 of 4 | |
| 10 |  XFOR X4 Pharmaceuticals Inc | $1.6M | 1.6% | 352K | New position | 1 of 4 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 STT State Str Corp | $2.1M | 17K |
 ATHM Autohome Inc | $2.1M | 121K |
 CALM Cal Maine Foods Inc | $2M | 25K |
 AXSM Axsome Therapeutics Inc | $1M | 5,971 |
 CVX Chevron Corp New | $936K | 4,525 |
🔒 Free account: see all 30.
Reported value
last 4 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Verdad Advisers 13F FAQ
What does Verdad Advisers own?
Verdad Advisers reported 210 stocks worth $104M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are AAPL (2.1%), BLTE (2.0%) and ACAD (2.0%). The table above lists every position in the filing (the top 10 without an account).
What did Verdad Advisers buy and sell in Q2 2026?
Compared with Q1 2026: 97 new positions, 59 added to, 42 trimmed and 66 sold out. New positions include AAPL, XFOR and JBIO. It sold all of STT, ATHM and CALM.
When will Verdad Advisers file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Verdad Advisers's portfolio worth?
The Q2 2026 filing reports $104M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.